In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the potential of tumor necrosis factor-like ligand 1A ...

Please provide your email address to receive an email when new articles are posted on . “This is a really exciting new mechanism of action for our field, hoping to improve functional as well as ...

Dave Lahr, PhD, is currently leading the computational biology group at Foghorn Therapeutics, a biotech startup focused on treating diseases by correcting abnormal gene expression. In the early days ...

Conventional cancer drugs work by triggering apoptosis, that is programmed cell death, in tumor cells. However, tumor cells have the ability to develop strategies to escape apoptosis, rendering the ...

BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR UK USE – NOT INTENDED FOR UK MEDIA LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of ...

Using Action Mode inside the iPhone Camera app can help stabilize videos when there's a lot of movement or if your hands are ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for weight loss, to reduce the risk of serious cardiovascular problems, and to treat a serious liver problem called ...

Over 12 million people worldwide suffer from a chronic infection with the hepatitis D virus. This most severe viral liver disease is associated with a high risk of dying from liver cirrhosis and liver ...